- Home
- MVIS vs HRTX Comparison
MVIS vs HRTX Comparison
Compare MVIS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | HRTX |
|---|---|---|
| Founded | 1993 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.6M | 228.3M |
| IPO Year | 2010 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MVIS | HRTX |
|---|---|---|
| Price | $0.29 | $0.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.25 | ★ $4.50 |
| AVG Volume (30 Days) | ★ 8.9M | 4.7M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $664,000.00 | ★ $154,904,000.00 |
| Revenue This Year | $529.06 | $15.28 |
| Revenue Next Year | $168.46 | $20.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $0.30 | $0.38 |
| 52 Week High | $1.73 | $2.30 |
Technical Indicators
Market Signals| Indicator | MVIS | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 23.31 | 30.44 |
| Support Level | N/A | $0.38 |
| Resistance Level | $0.73 | $1.30 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 1.36 | 42.30 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.